{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:11:05Z","timestamp":1792624265490,"version":"4.5.0"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000030","name":"CDC core funding","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.antiviral.2016.03.013","type":"journal-article","created":{"date-parts":[[2016,3,22]],"date-time":"2016-03-22T23:15:57Z","timestamp":1458688557000},"page":"46-49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"special_numbering":"C","title":["In\u00a0vitro antiviral activity of adenosine analog NITD008 against tick-borne flaviviruses"],"prefix":"10.1016","volume":"130","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0409-7896","authenticated-orcid":false,"given":"Michael K.","family":"Lo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Yong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Liang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Flint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina F.","family":"Spiropoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2016.03.013_bib1","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.4161\/hv.23802","article-title":"Epidemiology of tick-borne encephalitis (TBE) in Europe and its prevention by available vaccines","volume":"9","author":"Amicizia","year":"2013","journal-title":"Hum. Vaccin Immunother."},{"key":"10.1016\/j.antiviral.2016.03.013_bib2","doi-asserted-by":"crossref","first-page":"a007161","DOI":"10.1101\/cshperspect.a007161","article-title":"HIV-1 antiretroviral drug therapy","volume":"2","author":"Arts","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.antiviral.2016.03.013_bib3","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1517\/14656566.2014.857656","article-title":"Sofosbuvir for the treatment of hepatitis C virus","volume":"15","author":"Asselah","year":"2014","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.antiviral.2016.03.013_bib4","doi-asserted-by":"crossref","first-page":"430","DOI":"10.12998\/wjcc.v3.i5.430","article-title":"Tick-borne encephalitis: a review of epidemiology, clinical characteristics, and management","volume":"3","author":"Bogovic","year":"2015","journal-title":"World J. Clin. Cases"},{"key":"10.1016\/j.antiviral.2016.03.013_bib5","first-page":"152","article-title":"Field evaluation of formalin inactivated Kyasanur forest disease virus tissue culture vaccine in three districts of Karnataka state","volume":"99","author":"Dandawate","year":"1994","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.antiviral.2016.03.013_bib6","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.vetmic.2009.08.024","article-title":"Zoonotic tick-borne flaviviruses","volume":"140","author":"Dobler","year":"2010","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.antiviral.2016.03.013_bib7","doi-asserted-by":"crossref","first-page":"e1352","DOI":"10.1371\/journal.pntd.0001352","article-title":"Ancient ancestry of KFDV and AHFV revealed by complete genome analyses of viruses isolated from ticks and mammalian hosts","volume":"5","author":"Dodd","year":"2011","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.antiviral.2016.03.013_bib8","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1128\/AAC.02393-14","article-title":"Inhibitors of the tick-borne, hemorrhagic fever-associated flaviviruses","volume":"58","author":"Flint","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2016.03.013_bib9","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0065-3527(03)61008-0","article-title":"Tick-borne flaviviruses","volume":"61","author":"Gritsun","year":"2003","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.antiviral.2016.03.013_bib10","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3201\/eid1901.120458","article-title":"Vaccination and tick-borne encephalitis, central Europe","volume":"19","author":"Heinz","year":"2013","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.03.013_bib11","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.antiviral.2012.10.005","article-title":"Kyasanur forest disease","volume":"96","author":"Holbrook","year":"2012","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.03.013_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coviro.2014.04.005","article-title":"Nucleoside\/nucleotide analog inhibitors of hepatitis B virus polymerase: mechanism of action and resistance","volume":"8","author":"Menendez-Arias","year":"2014","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.antiviral.2016.03.013_bib13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.antiviral.2015.07.008","article-title":"Combined treatment of adenosine nucleoside inhibitor NITD008 and histone deacetylase inhibitor vorinostat represents an immunotherapy strategy to ameliorate West Nile virus infection","volume":"122","author":"Nelson","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.03.013_bib14","first-page":"493","article-title":"A\u00a0simple method of estimating fifty percent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Hyg."},{"key":"10.1016\/j.antiviral.2016.03.013_bib15","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1016\/S0140-6736(10)61120-8","article-title":"Omsk haemorrhagic fever","volume":"376","author":"Ruzek","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2016.03.013_bib16","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.virol.2004.10.048","article-title":"Generation of eGFP expressing recombinant Zaire ebolavirus for analysis of early pathogenesis events and high-throughput antiviral drug screening","volume":"332","author":"Towner","year":"2005","journal-title":"Virol."},{"key":"10.1016\/j.antiviral.2016.03.013_bib17","doi-asserted-by":"crossref","first-page":"20435","DOI":"10.1073\/pnas.0907010106","article-title":"An adenosine nucleoside inhibitor of dengue virus","volume":"106","author":"Yin","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216300456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216300456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T00:29:25Z","timestamp":1536884965000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354216300456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":17,"alternative-id":["S0166354216300456"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.03.013","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In\u00a0vitro antiviral activity of adenosine analog NITD008 against tick-borne flaviviruses","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}